✦ LIBER ✦

354 LONG TERM RESULTS OF IMMEDIATE VERSUS DEFERRED ANDROGEN DEPRI-VATION IN PATIENTS WITH NO LOCAL TREATMENT FOR T0–4 N0–2 M0 PROSTATE CANCER (EORTC 30891)

✍ Scribed by Studer, Urs; Whelan, Peter; Albrecht, Walter; Wimpissinger, Florian; Casselman, Jacques; De Reijke, Theo M.; Kn̈onagel, Harmut; Madersbacher, Stefan; Isorna, Santiago; Sundaram, Subramanian K.; Collette, Laurence

Book ID: 123464622
Publisher: Lippincott Williams and Wilkins
Year: 2011
Tongue: English
Weight: 176 KB
Volume: 185
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2011.02.439

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

804 IMMEDIATE OR DEFERRED ANDROGEN DEPRI

804 IMMEDIATE OR DEFERRED ANDROGEN DEPRIVATION FOR PATIENTS WITH PROSTATE CANCER AND NO LOCAL TREATMENT OF THE PROSTATE: LONG TERM RESULTS OF EORTC 30891

✍ U.E. Studer; P. Whelan; W. Albrecht; F. Wimpissinger; J. Casselman; Th.M. De Rei 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 201 KB

WHICH PATIENTS WITH T0-4 N0 M0 PROSTATE

WHICH PATIENTS WITH T0-4 N0 M0 PROSTATE CANCER NOT SUITABLE FOR LOCAL TREATMENT WITH CURATIVE INTENT DO NOT NEED IMMEDIATE TREATMENT IN EORTC TRIAL 30891?

✍ L. Collette; U.E. Studer; P. Whelan; W. Albrecht; J. Casselman; T.M. De Reijke; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Using PSA to Guide Timing of Androgen De

Using PSA to Guide Timing of Androgen Deprivation in Patients with T0–4 N0–2 M0 Prostate Cancer not Suitable for Local Curative Treatment (EORTC 30891)

✍ Urs E. Studer; Laurence Collette; Peter Whelan; Walter Albrecht; Jacques Casselm 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 757 KB

IS THE DEGREE OF PSA DECLINE AFTER IMMED

IS THE DEGREE OF PSA DECLINE AFTER IMMEDIATE ANDROGEN DEPRIVATION A PROGNOSTIC FACTOR FOR OUTCOME IN PATIENTS WITH T0-4 N0 M0 PROSTATE CANCER NOT SUITABLE FOR LOCAL TREATMENT WITH CURATIVE INTENT? (RESULTS FROM THE EORTC 30891 TRIAL)

✍ Collette, L.; Studer, U.E.; Whelan, P.; Albrecht, W.; Casselman, J.; De Reijke, 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB

PSA DOUBLING TIME AS PREDICTOR OF OBJECT

PSA DOUBLING TIME AS PREDICTOR OF OBJECTIVE PROGRESSION AND DEATH IN PATIENTS WITH T0-4 N0-2 M0 PROSTATE CANCER NOT SUITABLE FOR LOCAL DEFINITIVE TREATMENT ON WATCHFUL WAITING (EORTC 30891)

✍ L. Collette; U.E. Studer; P. Whelan; W. Albrecht; J. Casselman; T.M. De Reijke; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Re: Urs E. Studer, Laurence Collette, Pe

Re: Urs E. Studer, Laurence Collette, Peter Whelan, et al. Using PSA to Guide Timing of Androgen Deprivation in Patients with T0–4 N0–2 M0 Prostate Cancer not Suitable for Local Curative Treatment (EORTC 30891). Eur Urol 2008;53:941–9

✍ Narasimhan Ragavan; Paras B. Singh; Francis L. Martin; Andrew D. Baird 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB